McClarren Financial Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10
| Closed | – | – | 402 |
|
|
2023
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 406 |
|
|
2023
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 379 |
|
|
2023
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 423 |
|
|
2023
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 422 |
|
|
2022
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 428 |
|
|
2022
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 323 |
|
|
2022
Q2 | – | Sell |
-10
| Closed | – | – | 179 |
|
|
2022
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 297 |
|
|
2021
Q4 | $3K | Hold |
10
| – | – | ﹤0.01% | 282 |
|
|
2021
Q3 | $2K | Sell |
10
-22
| -69% | -$4.4K | ﹤0.01% | 260 |
|
|
2021
Q2 | $8K | Buy |
32
+22
| +220% | +$5.5K | 0.01% | 233 |
|
|
2021
Q1 | $3K | Hold |
10
| – | – | ﹤0.01% | 233 |
|
|
2020
Q4 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 204 |
|